RSS Alerts

Share

More services

Related Links

Related Stories

  • BioWales back with hot topics for 2010
    BioWales will return in 2010 to showcase the bioscience sector in Wales to an international, commercial and academic audience of 400 delegates with a brokerage event and exhibition and a conference covering hot topics such as stem cells.
  • Proceedings of the 2nd Annual London Genetics Pharmacogenetics conference 2010 Pharmacogenetics: Why, How and When?
    The importance of pharmacogenetics and stratified medicine as part of the drug development processes is now widely acknowledge, offering the opportunity to address many of the challenges facing the biopharmaceutical industry today and supporting an era where cost-effectiveness and value-based pricing rule. Moving on from the inaugural London Genetics Pharmacogenetic conference in 2009, at which the role of pharmacogenetics in drug discovery and development was debated, the 2nd London Genetics conference, entitled ‘Pharmacogenetics – Why, How and When?’ focused on how and when to apply stratified approaches from drug discovery through to cost-effectiveness evaluation and reimbursement.
  • Therapeutic peptides – a revival of interest
    The innovation process in the pharmaceutical industry is, as for all evolutionary models of technological change, both ‘pushed by technology’ and ‘demand driven’. The core of the innovation relies on the research for new high value-added drugs to address unmet medical needs. To this end, tens of billions of dollars are invested per year in R&D. However, the decreasing number of approved drugs, which is accompanied by increasing R&D expenditures, demands alternative approaches to increase R&D productivity. This situation contributes to a revival of interest in peptides as potential tools and drug candidates.
  • Biowales March 1 and 2 Showcases Country’s Biosciences Sector
    BioWales 2011 returns to the Vale Hotel near Cardiff on March 1st and 2nd with a conference, exhibition and biopartnering event reflecting the significance of the life sciences sector in Wales. Bringing together industry professionals, academics and clinicians, BioWales sets a platform to promote breakthroughs in new technologies, gain insights into the latest trends and developments and make valuable connections.
  • New treatments for stroke, hypertension and heart disease under microscope
    Potential new ways of treating people suffering from high blood pressure, stoke and heart disease, will be highlighted at a major international gathering of pharmacologists in London.

Top 5 Stories

News

Cambridge, UK to host BioFine Europe 2010

03 February 2010

BioFine Europe 2010 will take place from 30–31 March and features The Peptide Conference 2010, the Synthetic Biology in Pharma conference and the BioFine Europe Exhibition.

BioFine Europe 2010 will take place at The Wellcome Trust Conference Centre, Cambridge, UK.

The Peptide Conference 2010

The Peptide Conference 2010 features researchers and experts from peptide therapeutics development presenting the latest scientific and technological knowledge in these areas of life sciences. The applications of peptide chemistry – from synthesis, through purification and analytics, to bioactivity testing in biotechnology, biomedical and other applications – from analytical to industrial scales will be presented.

Senior R&D scientists, managers and decision makers from pharmaceutical and biotechnology companies looking to develop new peptide analytics, therapeutics and diagnostics could all benefit from attending the conference.

The Synthetic Biology in Pharma conference

The Synthetic Biology in Pharma conference focuses on recent advances in the application of synthetic biology technologies in the fields of biopharmaceuticals and small-molecule therapeutics. Enabling technologies that are accelerating the development of new applications will be presented, in addition to new bioproduction technologies for new pharmaceuticals (thus covering the complete range of development from initial research to final production strategies).

Senior R&D scientists, managers and decision makers from pharmaceutical and biotechnology companies looking to apply synthetic biology in pharmaceutical discovery and development could all benefit from attending the conference.

This conference was organized jointly by avakado media and ATG: biosynthetics GmbH.

Registration

Delegate registration covers attendance at either conference, plus exhibition entrance and the Networking Reception. Academics, including postdoctoral researchers and faculty working in universities, technology colleges or other educational institutions, can benefit from an academic rate.

For further information on attending the conferences as a delegate, contact Tom Mulligan (tom@avakado.eu).

BioFine Europe exhibition

The BioFine Europe Exhibition takes place alongside the conferences at The Wellcome Trust Conference Centre, Cambridge, UK, from Tuesday 30 March to Wednesday 31 March, 2010. Suppliers of technologies, services and products will present their offerings supporting drug discovery and development programmes.

The exhibition opening hours are from 09.00 to 17.00 on both days of the event. Confirmed exhibitors include Almac Sciences, Biotage AB, Eurogentec, Pepceuticals and TCI Europe.

BioFine Europe 2010 is sponsored by CBL Patras, Activotec and Peptisyntha. For exhibition and sponsorship opportunities, contact Jaymin Amin (jaymin@avakado.eu).

 

This article is featured in:
Companies and People  •  Pharmacology/ Therapeutics

 

Comment on this article

You must be registered and logged in to leave a comment about this article.

Copyright © 2012
Elsevier Ltd. All rights reserved.
Terms & Conditions | Privacy | Website Design Working with water